Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial (2012)
- Authors:
- USP affiliated authors: MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; FOSSALUZA, VICTOR - IME
- Unidades: FM; IME
- DOI: 10.1016/j.janxdis.2011.08.008
- Subjects: TERAPIA COGNITIVA; SEROTONINA (ANTAGONISTAS E INIBIDORES); TRANSTORNO OBSESSIVO-COMPULSIVO; GRUPOS CONTROLE; PRÁTICA PROFISSIONAL
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of anxiety disorders
- ISSN: 0887-6185
- Volume/Número/Paginação/Ano: v. 26, n. 1, p. 25\201331, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BELOTTO-SILVA, Cristina et al. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial. Journal of anxiety disorders, v. 26, n. 1, p. 25\201331, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.janxdis.2011.08.008. Acesso em: 29 dez. 2025. -
APA
Belotto-Silva, C., Diniz, J. B., Malavazzi, D. M., Valério, C., Fossaluza, V., Borcato, S., et al. (2012). Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial. Journal of anxiety disorders, 26( 1), 25\201331. doi:10.1016/j.janxdis.2011.08.008 -
NLM
Belotto-Silva C, Diniz JB, Malavazzi DM, Valério C, Fossaluza V, Borcato S, Seixas AA, Morelli D, Miguel Filho EC, Shavitt RG. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial [Internet]. Journal of anxiety disorders. 2012 ; 26( 1): 25\201331.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.janxdis.2011.08.008 -
Vancouver
Belotto-Silva C, Diniz JB, Malavazzi DM, Valério C, Fossaluza V, Borcato S, Seixas AA, Morelli D, Miguel Filho EC, Shavitt RG. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial [Internet]. Journal of anxiety disorders. 2012 ; 26( 1): 25\201331.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.janxdis.2011.08.008 - Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever
- Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
- Comorbid major depression in obsessive-compulsive disorder patients
- Higher prevalence of obsessive-compulsive and related disorders in rheumatic fever
- Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- Validation of the University of Sao Paulo Sensory Phenomena Scale: Initial Psychometric Properties
Informações sobre o DOI: 10.1016/j.janxdis.2011.08.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
